Global Blood Therapeutics, Inc.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Global Blood Therapeutics, Inc. Common, CUSIP 378904108.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Global Blood Therapeutics, Inc. Common, CUSIP 378904108.